fbpx Concerns about Patient Access to Biopharmaceuticals and Outcomes | Harvard Kennedy School

HKS Affiliated Authors

Ethel Zimmerman Wiener Professor of Public Policy, HKS; Henry and Allison McCance Professor of Business Administration, HBS


January 18, 2023, Paper: "A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices."